We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression and neurodegenerative disorders by using peptide-based and brain activ... Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression and neurodegenerative disorders by using peptide-based and brain active therapeutics. The company's lead compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.3801 | -23.3190184049 | 1.63 | 1.79 | 1.1535 | 4191 | 1.40168481 | CS |
4 | -0.1301 | -9.42753623188 | 1.38 | 1.87 | 1.1535 | 9542 | 1.66491792 | CS |
12 | 0.359799 | 40.4222666866 | 0.890101 | 1.87 | 0.76 | 10786 | 1.28460082 | CS |
26 | 0.3838 | 44.3135896548 | 0.8661 | 1.87 | 0.6797 | 8550 | 1.10983309 | CS |
52 | -0.5501 | -30.5611111111 | 1.8 | 2.32 | 0.6797 | 8620 | 1.28396148 | CS |
156 | -9.7501 | -88.6372727273 | 11 | 19.56 | 0.6797 | 446454 | 11.27116536 | CS |
260 | -9.7501 | -88.6372727273 | 11 | 19.56 | 0.6797 | 446454 | 11.27116536 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions